Literature DB >> 7229028

Effect of parathyroid hormone on erythropoiesis.

D Meytes, E Bogin, A Ma, P P Dukes, S G Massry.   

Abstract

Inhibitors of erythropoiesis have been found in the blood of uremic patients but their nature has not been identified. These patients have excess blood levels of parathyroid hormone (PTH) and it is possible that PTH inhibits erythropoiesis. The present study was undertaken to examine the effect of intact PTH molecules and some of its fragments on human peripheral blood and mouse bone marrow burst-forming units-erythroid (BFU-E), on mouse bone marrow erythroid colony-forming unit (CFU-E), and granulocyte macrophage progenitors (CFU-GM), and evaluate the interaction between PTH and erythropoietin (Ep) on human BFU-E. Intact PTH (1-84 bPTH) in concentrations (7.5-30 U/ml;) comparable to those found in blood of uremic patients produced marked and significant (P less than 0.01) inhibition of BFU-E and mouse marrow GFU-GM, but not of mouse marrow CFU-E. Inactivation of 1-84 bPTH abolished its action on erythropoiesis. Increasing the concentration of Ep in the media from 0.67 to 1.9 U/ml overcame the inhibitory effect of 1-84 bPTH on BFU-E. The N-terminal fragment of PTH (1-34 bPTH) and 53-84 hPTH had no effect on BFU-E. The results demonstrate that (a) either the intact PTH molecule or a C-terminal fragment(s) bigger than 53-84 moiety exerts the inhibitory effect on erythropoiesis, and (b) adequate amounts of Ep can overcome this action of PTH. The data provide one possible pathway for the participation of excess PTH in the genesis of the anemia of uremia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7229028      PMCID: PMC370692          DOI: 10.1172/jci110154

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

Review 1.  Relationships between calcium and cyclic nucleotides in cell activation.

Authors:  H Rasmussen; D B Goodman
Journal:  Physiol Rev       Date:  1977-07       Impact factor: 37.312

2.  Primary hyperparathyroidism: clinical and biochemical features.

Authors:  L E Mallette; J P Bilezikian; D A Heath; G D Aurbach
Journal:  Medicine (Baltimore)       Date:  1974-03       Impact factor: 1.889

3.  Calcium metabolism at the cellular level.

Authors:  A B Borle
Journal:  Fed Proc       Date:  1973-09

4.  Partial purification and some properties of the factor in normal and leukaemic human urine stimulating mouse bone marrow colony growth in vitro.

Authors:  E R Stanley; D Metcalf
Journal:  Aust J Exp Biol Med Sci       Date:  1969-08

5.  Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy.

Authors:  A I Katz; C L Hampers; J P Merrill
Journal:  Medicine (Baltimore)       Date:  1969-09       Impact factor: 1.889

6.  Central nervous system manifestations of hyperparathyroidism.

Authors:  M G Cogan; C M Covey; A I Arieff; A Wisniewski; O H Clark; V Lazarowitz; W Leach
Journal:  Am J Med       Date:  1978-12       Impact factor: 4.965

7.  Plasma erythropoietin in chronic uraemia.

Authors:  R Brown
Journal:  Br Med J       Date:  1965-10-30

8.  Calcium and ionophore A-23187 as initiators of DNA replication in the pluripotent haemopoietic stem cell.

Authors:  O Gallien-Lartigue
Journal:  Cell Tissue Kinet       Date:  1976-11

9.  Inhibitors of erythroid colony-forming cells (CFU-E and BFU-E) in sera of azotemic patients with anemia of renal disease.

Authors:  Y Ohno; A B Rege; J W Fisher; J Barona
Journal:  J Lab Clin Med       Date:  1978-12

10.  Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin.

Authors:  L R Chase; G D Aurbach
Journal:  Science       Date:  1968-02-02       Impact factor: 47.728

View more
  30 in total

1.  Parathyroid hormone and anaemia--an erythrocyte osmotic fragility study in primary and secondary hyperparathyroidism.

Authors:  C J Foulks; G M Mills; L F Wright
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

Review 2.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

3.  Altered Expression Pattern of CD55 and CD59 on Red Blood Cells in Anemia of Chronic Kidney Disease.

Authors:  Lama Al-Faris; Salah Al-Humood; Fatma Behbehani; Husam Sallam
Journal:  Med Princ Pract       Date:  2017-09-28       Impact factor: 1.927

4.  Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm.

Authors:  I C Macdougall; R D Hutton; I Cavill; G A Coles; J D Williams
Journal:  BMJ       Date:  1990-03-10

5.  The role of parathyroidectomy in JAK2 mutation negative polycythemia vera.

Authors:  Afif N Kulaylat; Eric E Jung; Brian D Saunders
Journal:  Int J Hematol       Date:  2014-09-11       Impact factor: 2.490

Review 6.  The use of erythropoietin in renal failure.

Authors:  I C Macdougall; R D Hutton; G A Coles; J D Williams
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

7.  The case for routine parathyroid hormone monitoring.

Authors:  Stuart M Sprague; Sharon M Moe
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

8.  Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease.

Authors:  Lac Tran; Michael Batech; Connie M Rhee; Elani Streja; Kamyar Kalantar-Zadeh; Steven J Jacobsen; John J Sim
Journal:  Nephrol Dial Transplant       Date:  2015-08-08       Impact factor: 5.992

9.  Mice lacking the sodium-dependent phosphate import protein, PiT1 (SLC20A1), have a severe defect in terminal erythroid differentiation and early B cell development.

Authors:  Li Liu; Marilyn Sánchez-Bonilla; Matthew Crouthamel; Cecilia Giachelli; Siobán Keel
Journal:  Exp Hematol       Date:  2013-01-30       Impact factor: 3.084

10.  The association between parathyroid hormone and mortality in dialysis patients is modified by wasting.

Authors:  Christiane Drechsler; Vera Krane; Diana C Grootendorst; Eberhard Ritz; Karl Winkler; Winfried März; Friedo Dekker; Christoph Wanner
Journal:  Nephrol Dial Transplant       Date:  2009-05-27       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.